No Data
No Data
Intel Group: Report for the third quarter of 2024
Zhejiang Int'l Group (000411.SZ): The net income for the first three quarters was 0.355 billion yuan, a year-on-year decrease of 2.90%.
On October 29, Geelonghui reported the third quarter of 2024 for Zhejiang Int'l Group (000411.SZ), with the company achieving revenue of 24.777 billion yuan in the first three quarters, a year-on-year increase of 3.59%; net income attributable to shareholders of the listed company was 0.355 billion yuan, a year-on-year decrease of 2.90%; net income attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 0.34 billion yuan, a year-on-year increase of 24.54%; basic earnings per share were 0.6868 yuan.
zhejiang int'l group (000411.SZ) released its performance for the first three quarters, with a net income of 0.355 billion yuan, a year-on-year decrease of 2.90%.
Zhejiang Int'l Group (000411.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...
Zhejiang Int'l Group (000411.SZ): The controlling shareholder has been changed from Zhejiang Guomao to Zhejiang Pharmaceutical Group.
On October 16th, GeLongHui reported that Zhejiang International Group (000411.SZ) announced that the shareholder Zhejiang Huachen Investment Development Co., Ltd. (referred to as "Huachen Investment") transferred its 122,277,151 shares of the company held to its holding shareholder Zhejiang Medicine and Health Industry Group Co., Ltd. (referred to as "Zhejiang Medicine Group" and "acquirer") for free; meanwhile, the company's controlling shareholder Zhejiang International Trade Group Co., Ltd. (referred to as "Zhejiang Guomao") entrusted the corresponding voting rights of its 150,846,487 shares to its wholly-owned subsidiary Zhejiang Medicine Group owned by Zhejiang Guomao. This transaction.
There's No Escaping Zhejiang Int'l Group Co.,Ltd.'s (SZSE:000411) Muted Earnings
Zhejiang Int'l Group: Half-year report for the year 2024.